Method for enriching and purifying blood platelets
A platelet enrichment technology, applied in the field of biomedicine, can solve the problems of low PRP concentration or purity, white blood cell and red blood cell contamination, plasma residual quality, etc., to avoid potential adverse reactions, reduce pollution, and improve the effect of enrichment purity.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] (1) Collect human whole blood into vacuum blood collection tubes containing sodium citrate, the mass concentration of sodium citrate being 3.2% to 3.8%. The volume ratio of anticoagulant to whole blood is 1:9. 3 mL whole blood was collected.
[0037] (2) Fully mix the blood and anticoagulant to avoid coagulation.
[0038] (3) Distribute 3 mL of blood containing anticoagulants into centrifuge tubes and centrifuge at 1000 rpm for 10 minutes. After centrifugation, the blood should be divided into three layers: the bottom layer is red blood cells, the top layer is platelet-poor layer, and the middle layer is platelet-rich layer. Contains platelets and white blood cells.
[0039] (4) Use a pipette to extract the uppermost layer and the middle layer and transfer them to a new centrifuge tube without intentionally avoiding the extraction of red blood cells to obtain enrichment A.
[0040] (5) Add 1 mL of normal saline to the original centrifuge tube containing the remaining...
Embodiment 2
[0052] Example 2: Preparation of concentrated platelets
[0053] The operation steps are the same as in Example 1, except that in step (6), the erythrocyte lysate is a lymphocyte separation liquid (P8610-200, Shanghai Suo Laibao Biotechnology Co., Ltd.), and the lymphocyte separation liquid and enrichment C The volume ratio is 1:1.
[0054] The prepared human, rat and mouse platelets have a purity of more than 99%.
Embodiment 3
[0055] Example 3: Preparation of concentrated platelets
[0056] The operation steps are the same as in Example 1, except that in step (1), heparin (15 IU / mL) is used as the anticoagulant, and the volume ratio of anticoagulant to whole blood is 1:9.
[0057] The prepared human, rat and mouse platelets have a purity of more than 99%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com